A new age-related macular degeneration discovery Scientists have got won a major battle in the fight against age-related macular degeneration, or AMD, a blinding vision disease that affects thousands of people. In the February edition of the medical journal PLoS Medicine, the researchers explain how a deficiency of the CD36 receptor stops the evacuation of oxidized lipids in the attention. Related StoriesDrug used to take care of Parkinson's and related diseases may delay or prevent macular degenerationAstellas enters into definitive contract to acquire OcataCharles Bonnet syndrome: an interview with Dr.A combined positron-emission tomographic and computed tomographic scan revealed extensive skeletal and soft-cells metastases Scanning.). The individual was referred for consideration of enrollment in the phase 1 trial of GDC-0449. He didn’t meet enrollment criteria owing to the hematologic abnormalities. The pancytopenia was regarded as consistent with considerable marrow involvement. No clinically significant hematologic toxic effects had been observed in the clinical trials of GDC-0449 up to that time.